Tong, V., Raynor, D. K., Blalock, S. J., & Aslani, P. (2015). Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies. Patient Prefer Adherence.
Styl cytowania ChicagoTong, Vivien, David K. Raynor, Susan J. Blalock, i Parisa Aslani. "Consumer Interpretation of Ramipril and Clopidogrel Medication Risk Information – Implications for Risk Communication Strategies." Patient Prefer Adherence 2015.
Styl cytowania MLATong, Vivien, David K. Raynor, Susan J. Blalock, i Parisa Aslani. "Consumer Interpretation of Ramipril and Clopidogrel Medication Risk Information – Implications for Risk Communication Strategies." Patient Prefer Adherence 2015.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..